Authors: WIESLANDER E DELANDER EL JARKELID L HJERTBERG E TUNEK A BRATTSAND R

Citation: E. Wieslander et al., PHARMACOLOGICAL IMPORTANCE OF THE REVERSIBLE FATTY-ACID CONJUGATION OF BUDESONIDE STUDIED IN A RAT-CELL LINE IN-VITRO, American journal of respiratory cell and molecular biology, 19(3), 1998, pp. 477-484

Authors: WIESLANDER E ENGMAN L SVENSJO E ERLANSSON M JOHANSSON U LINDEN M ANDERSSON CM BRATTSAND R

Citation: E. Wieslander et al., ANTIOXIDATIVE PROPERTIES OF ORGANOTELLURIUM COMPOUNDS IN CELL SYSTEMS, Biochemical pharmacology, 55(5), 1998, pp. 573-584

Authors: MCKAY DM BRATTSAND R WIESLANDER E FUNG M CROITORU K PERDUE MH

Citation: Dm. Mckay et al., BUDESONIDE INHIBITS T-CELL-INITIATED EPITHELIAL PATHOPHYSIOLOGY IN ANIN-VITRO MODEL OF INFLAMMATION, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 403-410

Authors: MCKAY DM BRATTSAND R WIESLANDER E PERDUE MH

Citation: Dm. Mckay et al., BUDESONIDE INHIBITS IMMUNE CELL ACTIVATION AND EPITHELIAL PATHOPHYSIOLOGY IN COCULTURE STUDIES, Gastroenterology, 108(4), 1995, pp. 873-873

Authors: MAIN C BRATTSAND R JARKELID L WIESLANDER E

Citation: C. Main et al., NEUTROPHIL-MEDIATED IMPAIRMENT OF COLONIC EPITHELIAL-CELL (CACO-2) BARRIER FUNCTION - EFFECTS OF PROTEASE INHIBITORS AND ANTIOXIDANTS, Gastroenterology, 106(4), 1994, pp. 10000727-10000727

Authors: WIESLANDER E MAIN C JARKELID L BRATTSAND R

Citation: E. Wieslander et al., EFFECTS OF ACTIVATED PHAGOCYTES ON A CULTURED COLONIC EPITHELIAL-CELLLINE, CACO-2, Gastroenterology, 104(4), 1993, pp. 801-801